TXG Stock Analysis: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$39.01
-0.04 (-0.10%)
▼
5d:
+9.18%
30d:
+27.03%
90d:
+76.92%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: TXG is 8.7% above its trading range ($35.90). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: TXG is 8.7% above its trading range ($35.90). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $39.01, which is considered extended relative to its 30-day fair value range of $28.29 to $35.90. From a valuation perspective, the stock is trading at a premium (Forward PE: 195.1) compared to its historical average (131.6). At these levels, the market is pricing in 14.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TXG is in a uptrend. The price is approaching resistance at $35.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TXG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $27.62. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TXG is in a uptrend. The price is approaching resistance at $35.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TXG has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $27.62. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$28.29 -
$35.90
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.7%
All Signals
- BEARISH: Price extended above range (+8.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 29.2% above Wall St target ($27.62)
- NEUTRAL: Trading at premium valuation - market expects 14.0% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$28.29 -
$35.90
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$23.72
Resistance Level
$35.65
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
195.05
Wall Street Target
$27.62
(-29.2%)
Revenue Growth (YoY)
-2.6%
Profit Margin
-3.5%
Valuation Premium vs History
+14.0% premium
PE vs Historical
195.1 vs 131.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+14.0%
(market-implied from PE analysis)
1-Year Target
$44.47
(+14%)
2-Year Target
$50.70
(+30%)
3-Year Target
$57.80
(+48%)
3-Yr Target (if PE normalizes)
(PE: 195→132)
PE COMPRESSION
$38.99
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 05, 2026 1:27 AM ET
Data refreshes hourly during market hours. Next update: 2:27 AM
Data refreshes hourly during market hours. Next update: 2:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Serge Saxonov
SELL
5000 shares
2026-03-24
Serge Saxonov
SELL
10000 shares
2026-03-23
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 61 BUY |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 66 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 63 BUY |
